| Dr Willie Harrington Iii, MD | |
|
1100 Alabama Ave Se, Washington, DC 20032-4540 | |
| (202) 299-5000 | |
| Not Available |
| Full Name | Dr Willie Harrington Iii |
|---|---|
| Gender | Male |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 1100 Alabama Ave Se, Washington, District Of Columbia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083064927 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | MTL003505 (District Of Columbia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Willie Harrington Iii, MD 10412 Julep Ave, Silver Spring, MD 20902-3840 Ph: (678) 371-9376 | Dr Willie Harrington Iii, MD 1100 Alabama Ave Se, Washington, DC 20032-4540 Ph: (202) 299-5000 |
News Archive
In a new study, researchers developed a gene expression predictor that can indicate whether melanoma in a specific patient is likely to respond to treatment with immune checkpoint inhibitors, a novel type of immunotherapy.
The Muscular Dystrophy Association, which has invested almost $39 million in 2010 in worldwide research seeking treatments and cures for muscle diseases, today announced that it has awarded $14.1 million in new grants.
ACCESS PHARMACEUTICALS, INC.,a biopharmaceutical company specializing in products for cancer and supportive care, announced that its Director of Chemistry and Quality, Dr. Ric Zarzycki will give an invited presentation today on the Company's Cobalamin nanoparticle technology at a thought-leadership symposium being held at the American Chemical Society's ("ACS") 240th National Meeting & Exposition, at Boston Convention and Exhibition Center in Boston, Massachusetts, August 22-26, 2010.
Johns Hopkins Kimmel Cancer Center researchers say preliminary studies show that a vaccine made with leukemia cells may be able to reduce or eliminate the last remaining cancer cells in some chronic myeloid leukemia (CML) patients taking the drug Imatinib mesylate (Gleevec).
› Verified 9 days ago
Mr. Joel Edward Kleinman, M.D., PH.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 3734 Jenifer St Nw, Washington, DC 20015 Phone: 202-363-4846 Fax: 202-363-2025 | |
Dr. John Shill, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 2220 20th St Nw, Ste 71, Washington, DC 20009 Phone: 202-320-4417 | |
Nubia Amparo Chong, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1300 I St Nw Ste 400e, Washington, DC 20005 Phone: 202-902-7324 Fax: 848-213-0063 | |
Dr. Jerrold Thomas O'rourke Jr., M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1330 New Hampshire Ave Nw, Ste 113, Washington, DC 20036 Phone: 202-463-6634 Fax: 202-463-6638 | |
Dr. Jaime Suarez, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 2401 E Street Nw - M/med/qi - Sa-1, Department Of State, Washington, DC 20522 Phone: 202-663-2453 Fax: 202-663-3247 | |
Dr. Estela M. Gonzalez, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 2333 Ontario Rd Nw, Washington, DC 20009 Phone: 202-420-7121 | |
Dr. Richard Martin Restak, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1800 R St Nw, Suite C-3, Washington, DC 20009 Phone: 202-462-0455 Fax: 202-462-0340 |